Logo image of LNDC

LANDEC CORP (LNDC) Stock Fundamental Analysis

NASDAQ:LNDC - Nasdaq - US5147661046 - Common Stock - Currency: USD

8.76  -0.32 (-3.52%)

After market: 8.76 0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to LNDC. LNDC was compared to 89 industry peers in the Food Products industry. LNDC has a bad profitability rating. Also its financial health evaluation is rather negative. LNDC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

LNDC had negative earnings in the past year.
In the past year LNDC has reported a negative cash flow from operations.
In multiple years LNDC reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: LNDC reported negative operating cash flow in multiple years.
LNDC Yearly Net Income VS EBIT VS OCF VS FCFLNDC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M -20M -40M -60M -80M

1.2 Ratios

Industry RankSector Rank
ROA -38.31%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LNDC Yearly ROA, ROE, ROICLNDC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -20 -40 -60 -80

1.3 Margins

Industry RankSector Rank
OM -4.67%
PM (TTM) -47.78%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LNDC Yearly Profit, Operating, Gross MarginsLNDC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 20 -20 -40

1

2. Health

2.1 Basic Checks

LNDC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LNDC has more shares outstanding
The debt/assets ratio for LNDC is higher compared to a year ago.
LNDC Yearly Shares OutstandingLNDC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M
LNDC Yearly Total Debt VS Total AssetsLNDC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

LNDC has an Altman-Z score of 1.29. This is a bad value and indicates that LNDC is not financially healthy and even has some risk of bankruptcy.
LNDC has a Debt/Equity ratio of 0.99. This is a neutral value indicating LNDC is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF N/A
Altman-Z 1.29
ROIC/WACCN/A
WACC9.27%
LNDC Yearly LT Debt VS Equity VS FCFLNDC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 100M 200M

2.3 Liquidity

LNDC has a Current Ratio of 1.40. This is a normal value and indicates that LNDC is financially healthy and should not expect problems in meeting its short term obligations.
LNDC has a Quick Ratio of 1.40. This is a bad value and indicates that LNDC is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.63
LNDC Yearly Current Assets VS Current LiabilitesLNDC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

2

3. Growth

3.1 Past

LNDC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -56.52%.
Looking at the last year, LNDC shows a very negative growth in Revenue. The Revenue has decreased by -35.50% in the last year.
LNDC shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -16.93% yearly.
EPS 1Y (TTM)-56.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-39.13%
Revenue 1Y (TTM)-35.5%
Revenue growth 3Y-30.67%
Revenue growth 5Y-16.93%
Sales Q2Q%4.14%

3.2 Future

LNDC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.42% yearly.
The Revenue is expected to decrease by -8.71% on average over the next years.
EPS Next Y-7.67%
EPS Next 2Y69.38%
EPS Next 3Y44.54%
EPS Next 5Y24.42%
Revenue Next Year9.57%
Revenue Next 2Y-1.04%
Revenue Next 3Y-5.59%
Revenue Next 5Y-8.71%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LNDC Yearly Revenue VS EstimatesLNDC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
LNDC Yearly EPS VS EstimatesLNDC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 0.6

1

4. Valuation

4.1 Price/Earnings Ratio

LNDC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 37.34, the valuation of LNDC can be described as expensive.
LNDC's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.25.
Industry RankSector Rank
PE N/A
Fwd PE 37.34
LNDC Price Earnings VS Forward Price EarningsLNDC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 49.59
LNDC Per share dataLNDC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as LNDC's earnings are expected to grow with 44.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y69.38%
EPS Next 3Y44.54%

0

5. Dividend

5.1 Amount

No dividends for LNDC!.
Industry RankSector Rank
Dividend Yield N/A

LANDEC CORP

NASDAQ:LNDC (11/14/2022, 8:00:00 PM)

After market: 8.76 0 (0%)

8.76

-0.32 (-3.52%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)10-06 2022-10-06/bmo
Earnings (Next)01-03 2023-01-03
Inst Owners71.18%
Inst Owner Change-1.53%
Ins Owners3.65%
Ins Owner Change0%
Market Cap259.26M
Analysts86
Price Target14.03 (60.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-535.13%
Min EPS beat(2)-1145.75%
Max EPS beat(2)75.49%
EPS beat(4)3
Avg EPS beat(4)-140.15%
Min EPS beat(4)-1145.75%
Max EPS beat(4)467.74%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-10.93%
Min Revenue beat(2)-22.06%
Max Revenue beat(2)0.2%
Revenue beat(4)3
Avg Revenue beat(4)20.75%
Min Revenue beat(4)-22.06%
Max Revenue beat(4)83.13%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 37.34
P/S 1.13
P/FCF N/A
P/OCF N/A
P/B 2.68
P/tB 3.83
EV/EBITDA 49.59
EPS(TTM)-0.36
EYN/A
EPS(NY)0.23
Fwd EY2.68%
FCF(TTM)-1.69
FCFYN/A
OCF(TTM)-0.9
OCFYN/A
SpS7.74
BVpS3.27
TBVpS2.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.31%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -4.67%
PM (TTM) -47.78%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.99
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 129.77%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 0.63
Altman-Z 1.29
F-Score4
WACC9.27%
ROIC/WACCN/A
Cap/Depr(3y)139.54%
Cap/Depr(5y)196.6%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-39.13%
EPS Next Y-7.67%
EPS Next 2Y69.38%
EPS Next 3Y44.54%
EPS Next 5Y24.42%
Revenue 1Y (TTM)-35.5%
Revenue growth 3Y-30.67%
Revenue growth 5Y-16.93%
Sales Q2Q%4.14%
Revenue Next Year9.57%
Revenue Next 2Y-1.04%
Revenue Next 3Y-5.59%
Revenue Next 5Y-8.71%
EBIT growth 1Y-282.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year316.61%
EBIT Next 3Y74.15%
EBIT Next 5Y43.58%
FCF growth 1Y-213.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-593.78%
OCF growth 3YN/A
OCF growth 5YN/A